Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis LANCET RHEUMATOLOGY Genovese, M. C., Smolen, J. S., Takeuchi, T., Burmester, G., Brinker, D., Rooney, T. P., Zhong, J., Mo Daojun, Saifan, C., Cardoso, A., Issa, M., Wu, W., Winthrop, K. L. 2020; 2 (6): E347–E357
View details for Web of Science ID 000547846500022